Chloride ion

Generic Name: Chloride ion

Drug Type: Small Molecule

Chemical Formula: Cl

CAS Number: 16887-00-6

Unique Ingredient Identifier: Q32ZN48698

Clinical Trials

Dexmedetomidine Vs Dexamethasone in Popliteal Nerve Block

Phase 4

Recruiting

Conditions: Ankle Disease
Ankle Injuries and Disorders
Foot Injury
Foot Diseases

Interventions: Drug: 0.9% Sodium chloride
Drug: 0.1mg/kg Dexamethasone
Drug: 0.05ug/kg Dexmedetomidine

First Posted Date: 2024-03-12

Last Posted Date: 2025-01-21

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT06304324

Locations: 🇵🇱
Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland

A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas

Phase 2

Recruiting

Conditions: Dercum's Disease

Interventions: Drug: CBL-514 injection
Drug: 0.9% Sodium chloride

First Posted Date: 2024-03-12

Last Posted Date: 2024-10-30

Lead Sponsor: Caliway Biopharmaceuticals Co., Ltd.

Target Recruit Count: 30

Registration Number: NCT06303570

Locations: 🇺🇸
Investigational Site 01, O'Fallon, Missouri, United States

The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery

Phase 4

Recruiting

Conditions: Surgical Complication

Interventions: Drug: Tranexamic Acid 100 MG/ML
Drug: 0.9%sodium chloride

First Posted Date: 2024-02-21

Last Posted Date: 2024-12-04

Lead Sponsor: St. Olavs Hospital

Target Recruit Count: 3000

Registration Number: NCT06270407

Locations: 🇳🇴
St Olav's University Hospital, Trondheim, Norway

Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery

Not Applicable

Recruiting

Conditions: Elective Cesarean Delivery

Interventions: Drug: Calcium Gluconate 10%
Drug: sodium chloride 0.9%

First Posted Date: 2024-02-01

Last Posted Date: 2025-01-28

Lead Sponsor: Rambam Health Care Campus

Target Recruit Count: 1180

Registration Number: NCT06235749

Locations: 🇮🇱
Shamir Medical Center, Be'er Ya'aqov, Israel
🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱
Edith Wolfson Medical Center, H̱olon, Israel

and more 1 locations

Dexamethasone Vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery

Phase 4

Recruiting

Conditions: Ankle Injuries and Disorders
Foot Injuries and Disorders

Interventions: Drug: 0.9%sodium chloride
Drug: Dexamethasone
Drug: Dexmedetomidine

First Posted Date: 2024-01-31

Last Posted Date: 2025-01-21

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT06233565

Locations: 🇵🇱
Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland
🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

Phase 4

Recruiting

Conditions: Hip Osteoarthritis
Hip Pain Chronic
Hip Arthropathy

Interventions: Drug: Dexamethasone
Drug: 0.9%sodium chloride
Drug: Dexmedetomidine

First Posted Date: 2024-01-31

Last Posted Date: 2024-04-29

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 30

Registration Number: NCT06233604

Locations: 🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland

Evaluate the Safety, Tolerability of BAT6026

Phase 1

Recruiting

Conditions: Dermatitis, Atopic

Interventions: Drug: Monoclonal antibody BAT6026
Drug: sodium chloride injection

First Posted Date: 2023-10-23

Last Posted Date: 2024-11-18

Lead Sponsor: Bio-Thera Solutions

Target Recruit Count: 33

Registration Number: NCT06094179

Locations: 🇨🇳
Jianzhong Zhang, Beijing, Beijing, China

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

Phase 4

Completed

Conditions: Osteoarthritis
Osteoarthritis, Hip

Interventions: Drug: 0.9%sodium chloride
Drug: 95% ethanol

First Posted Date: 2023-10-18

Last Posted Date: 2025-01-21

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT06087588

Locations: 🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland

The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.

Phase 4

Completed

Conditions: Osteo Arthritis Knee
Osteoarthritis

Interventions: Drug: 0.9% Sodium chloride
Drug: 95% ethanol

First Posted Date: 2023-10-18

Last Posted Date: 2025-01-21

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT06087601

Locations: 🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Phase 4

Completed

Conditions: Scoliosis Idiopathic
Scoliosis; Adolescence

Interventions: Drug: 0.9% sodium chloride
Drug: Dexamethasone
Drug: Dexmedetomidine

First Posted Date: 2023-10-17

Last Posted Date: 2025-01-21

Lead Sponsor: Poznan University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT06086431

Locations: 🇵🇱
Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy